share_log

Those Who Invested in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Are up 78%

Those Who Invested in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Are up 78%

那些五年前投資IDEXX Laboratories(納斯達克:IDXX)的人現在的收益增長了78%。
Simply Wall St ·  09/07 21:15

The simplest way to invest in stocks is to buy exchange traded funds. But the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the IDEXX Laboratories, Inc. (NASDAQ:IDXX) share price is 78% higher than it was five years ago, which is more than the market average. The 1.4% share price rise over the last year is decent, but not great.

在股票投資中,最簡單的方法是購買交易所交易基金。但事實上,如果以正確的價格購買高質量的企業,您可以獲得顯著的收益。例如,IDEXX Laboratories, Inc.(NASDAQ:IDXX)的股價比五年前高出78%,這超過了市場平均水平。過去一年中,股價上漲了1.4%,儘管不算太大。

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

現在值得更詳細地了解該公司的基本面,因爲這將幫助我們判斷長期股東回報是否與基礎業務的表現相匹配。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

雖然有效市場假說仍然被一些人教授,但被證明市場是過度反應的動態系統,投資者並不總是理性的。檢查市場情緒如何隨時間變化的一種方法是看一個公司的股價與其每股收益(EPS)之間的交互作用。

Over half a decade, IDEXX Laboratories managed to grow its earnings per share at 17% a year. This EPS growth is higher than the 12% average annual increase in the share price. Therefore, it seems the market has become relatively pessimistic about the company.

在過去的五年中,IDEXX Laboratories的每股收益增長率達到了17%。這個每股收益增長率高於12%的年均股價增長率。因此,市場對該公司相對悲觀。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖顯示了EPS隨時間變化的情況(點擊圖像以顯示確切值)。

big
NasdaqGS:IDXX Earnings Per Share Growth September 7th 2024
納斯達克GS: IDXX每股收益增長2024年9月7日

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

在購買或出售股票之前,我們始終建議對歷史增長趨勢進行仔細研究,可以在這裏找到相關信息。

A Different Perspective

不同的觀點

IDEXX Laboratories provided a TSR of 1.4% over the last twelve months. But that return falls short of the market. It's probably a good sign that the company has an even better long term track record, having provided shareholders with an annual TSR of 12% over five years. It may well be that this is a business worth popping on the watching, given the continuing positive reception, over time, from the market. Before spending more time on IDEXX Laboratories it might be wise to click here to see if insiders have been buying or selling shares.

IDEXX實驗室在過去十二個月內提供了1.4%的TSR。但這個回報值不及市場。有更好的長期歷史數據表明,該公司在過去五年中爲股東提供了12%的年度TSR。鑑於市場一直對其持續的積極反響,這可能是一個值得關注的業務。要在進一步關注IDEXX實驗室之前,可能明智的做法是點擊這裏查看內部人員是否一直在買賣股票。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,您可能在其他地方找到一家出色的企業進行投資。因此,請查看我們預計將實現盈利增長的公司的免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論